Medical Care
Mantle Cell Lymphoma Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 546884
- Pages: 112
- Figures: 177
- Views: 1
The global market for Mantle Cell Lymphoma Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mantle Cell Lymphoma Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Mantle Cell Lymphoma Treatment by region & country, by Type, and by Application.
The Mantle Cell Lymphoma Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mantle Cell Lymphoma Treatment.
Market Segmentation
By Company
Astex Pharmaceuticals, Inc.
Bayer AG
Bristol-Myers Squibb Company
Celgene Corporation
Cellular Biomedicine Group, Inc.
Eisai
EpiZyme, Inc.
Fate Therapeutics, Inc.
Genentech, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Hutchison MediPharma Limited
ImmunoGen, Inc.
Immunomedics, Inc.
Segment by Type:
Acalabrutinib
JCAR-017
JNJ-64052781
Acalisib
IGN-002
IMGN-529
AFM-11
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Mantle Cell Lymphoma Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Mantle Cell Lymphoma Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Mantle Cell Lymphoma Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mantle Cell Lymphoma Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Mantle Cell Lymphoma Treatment by region & country, by Type, and by Application.
The Mantle Cell Lymphoma Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mantle Cell Lymphoma Treatment.
Market Segmentation
By Company
Astex Pharmaceuticals, Inc.
Bayer AG
Bristol-Myers Squibb Company
Celgene Corporation
Cellular Biomedicine Group, Inc.
Eisai
EpiZyme, Inc.
Fate Therapeutics, Inc.
Genentech, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Hutchison MediPharma Limited
ImmunoGen, Inc.
Immunomedics, Inc.
Segment by Type:
Acalabrutinib
JCAR-017
JNJ-64052781
Acalisib
IGN-002
IMGN-529
AFM-11
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Mantle Cell Lymphoma Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Mantle Cell Lymphoma Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Mantle Cell Lymphoma Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Mantle Cell Lymphoma Treatment Product Introduction
1.2 Global Mantle Cell Lymphoma Treatment Market Size Forecast
1.3 Mantle Cell Lymphoma Treatment Market Trends & Drivers
1.3.1 Mantle Cell Lymphoma Treatment Industry Trends
1.3.2 Mantle Cell Lymphoma Treatment Market Drivers & Opportunity
1.3.3 Mantle Cell Lymphoma Treatment Market Challenges
1.3.4 Mantle Cell Lymphoma Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Mantle Cell Lymphoma Treatment Players Revenue Ranking (2023)
2.2 Global Mantle Cell Lymphoma Treatment Revenue by Company (2019-2024)
2.3 Key Companies Mantle Cell Lymphoma Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Mantle Cell Lymphoma Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Mantle Cell Lymphoma Treatment
2.6 Mantle Cell Lymphoma Treatment Market Competitive Analysis
2.6.1 Mantle Cell Lymphoma Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Mantle Cell Lymphoma Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mantle Cell Lymphoma Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Acalabrutinib
3.1.2 JCAR-017
3.1.3 JNJ-64052781
3.1.4 Acalisib
3.1.5 IGN-002
3.1.6 IMGN-529
3.1.7 AFM-11
3.1.8 Others
3.2 Global Mantle Cell Lymphoma Treatment Sales Value by Type
3.2.1 Global Mantle Cell Lymphoma Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Mantle Cell Lymphoma Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Mantle Cell Lymphoma Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Mantle Cell Lymphoma Treatment Sales Value by Application
4.2.1 Global Mantle Cell Lymphoma Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Mantle Cell Lymphoma Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Mantle Cell Lymphoma Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Mantle Cell Lymphoma Treatment Sales Value by Region
5.1.1 Global Mantle Cell Lymphoma Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Mantle Cell Lymphoma Treatment Sales Value by Region (2019-2024)
5.1.3 Global Mantle Cell Lymphoma Treatment Sales Value by Region (2025-2030)
5.1.4 Global Mantle Cell Lymphoma Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
5.2.2 North America Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
5.3.2 Europe Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
5.5.2 South America Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Mantle Cell Lymphoma Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Mantle Cell Lymphoma Treatment Sales Value
6.3 United States
6.3.1 United States Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
6.3.2 United States Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Mantle Cell Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
6.4.2 Europe Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Mantle Cell Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
6.5.2 China Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Mantle Cell Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
6.6.2 Japan Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Mantle Cell Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
6.7.2 South Korea Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Mantle Cell Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Mantle Cell Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
6.9.2 India Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Mantle Cell Lymphoma Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Astex Pharmaceuticals, Inc.
7.1.1 Astex Pharmaceuticals, Inc. Profile
7.1.2 Astex Pharmaceuticals, Inc. Main Business
7.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.1.4 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Astex Pharmaceuticals, Inc. Recent Developments
7.2 Bayer AG
7.2.1 Bayer AG Profile
7.2.2 Bayer AG Main Business
7.2.3 Bayer AG Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.2.4 Bayer AG Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Bayer AG Recent Developments
7.3 Bristol-Myers Squibb Company
7.3.1 Bristol-Myers Squibb Company Profile
7.3.2 Bristol-Myers Squibb Company Main Business
7.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.3.4 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Celgene Corporation Recent Developments
7.4 Celgene Corporation
7.4.1 Celgene Corporation Profile
7.4.2 Celgene Corporation Main Business
7.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.4.4 Celgene Corporation Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Celgene Corporation Recent Developments
7.5 Cellular Biomedicine Group, Inc.
7.5.1 Cellular Biomedicine Group, Inc. Profile
7.5.2 Cellular Biomedicine Group, Inc. Main Business
7.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.5.4 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Cellular Biomedicine Group, Inc. Recent Developments
7.6 Eisai
7.6.1 Eisai Profile
7.6.2 Eisai Main Business
7.6.3 Eisai Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.6.4 Eisai Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Eisai Recent Developments
7.7 EpiZyme, Inc.
7.7.1 EpiZyme, Inc. Profile
7.7.2 EpiZyme, Inc. Main Business
7.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.7.4 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 EpiZyme, Inc. Recent Developments
7.8 Fate Therapeutics, Inc.
7.8.1 Fate Therapeutics, Inc. Profile
7.8.2 Fate Therapeutics, Inc. Main Business
7.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.8.4 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Fate Therapeutics, Inc. Recent Developments
7.9 Genentech, Inc.
7.9.1 Genentech, Inc. Profile
7.9.2 Genentech, Inc. Main Business
7.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.9.4 Genentech, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Genentech, Inc. Recent Developments
7.10 Gilead Sciences, Inc.
7.10.1 Gilead Sciences, Inc. Profile
7.10.2 Gilead Sciences, Inc. Main Business
7.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.10.4 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Gilead Sciences, Inc. Recent Developments
7.11 GlaxoSmithKline Plc
7.11.1 GlaxoSmithKline Plc Profile
7.11.2 GlaxoSmithKline Plc Main Business
7.11.3 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.11.4 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 GlaxoSmithKline Plc Recent Developments
7.12 Hutchison MediPharma Limited
7.12.1 Hutchison MediPharma Limited Profile
7.12.2 Hutchison MediPharma Limited Main Business
7.12.3 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.12.4 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Hutchison MediPharma Limited Recent Developments
7.13 ImmunoGen, Inc.
7.13.1 ImmunoGen, Inc. Profile
7.13.2 ImmunoGen, Inc. Main Business
7.13.3 ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.13.4 ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 ImmunoGen, Inc. Recent Developments
7.14 Immunomedics, Inc.
7.14.1 Immunomedics, Inc. Profile
7.14.2 Immunomedics, Inc. Main Business
7.14.3 Immunomedics, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.14.4 Immunomedics, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.14.5 Immunomedics, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Mantle Cell Lymphoma Treatment Industrial Chain
8.2 Mantle Cell Lymphoma Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Mantle Cell Lymphoma Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Mantle Cell Lymphoma Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Mantle Cell Lymphoma Treatment Product Introduction
1.2 Global Mantle Cell Lymphoma Treatment Market Size Forecast
1.3 Mantle Cell Lymphoma Treatment Market Trends & Drivers
1.3.1 Mantle Cell Lymphoma Treatment Industry Trends
1.3.2 Mantle Cell Lymphoma Treatment Market Drivers & Opportunity
1.3.3 Mantle Cell Lymphoma Treatment Market Challenges
1.3.4 Mantle Cell Lymphoma Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Mantle Cell Lymphoma Treatment Players Revenue Ranking (2023)
2.2 Global Mantle Cell Lymphoma Treatment Revenue by Company (2019-2024)
2.3 Key Companies Mantle Cell Lymphoma Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Mantle Cell Lymphoma Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Mantle Cell Lymphoma Treatment
2.6 Mantle Cell Lymphoma Treatment Market Competitive Analysis
2.6.1 Mantle Cell Lymphoma Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Mantle Cell Lymphoma Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mantle Cell Lymphoma Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Acalabrutinib
3.1.2 JCAR-017
3.1.3 JNJ-64052781
3.1.4 Acalisib
3.1.5 IGN-002
3.1.6 IMGN-529
3.1.7 AFM-11
3.1.8 Others
3.2 Global Mantle Cell Lymphoma Treatment Sales Value by Type
3.2.1 Global Mantle Cell Lymphoma Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Mantle Cell Lymphoma Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Mantle Cell Lymphoma Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Mantle Cell Lymphoma Treatment Sales Value by Application
4.2.1 Global Mantle Cell Lymphoma Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Mantle Cell Lymphoma Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Mantle Cell Lymphoma Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Mantle Cell Lymphoma Treatment Sales Value by Region
5.1.1 Global Mantle Cell Lymphoma Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Mantle Cell Lymphoma Treatment Sales Value by Region (2019-2024)
5.1.3 Global Mantle Cell Lymphoma Treatment Sales Value by Region (2025-2030)
5.1.4 Global Mantle Cell Lymphoma Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
5.2.2 North America Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
5.3.2 Europe Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
5.5.2 South America Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Mantle Cell Lymphoma Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Mantle Cell Lymphoma Treatment Sales Value
6.3 United States
6.3.1 United States Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
6.3.2 United States Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Mantle Cell Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
6.4.2 Europe Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Mantle Cell Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
6.5.2 China Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Mantle Cell Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
6.6.2 Japan Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Mantle Cell Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
6.7.2 South Korea Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Mantle Cell Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Mantle Cell Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Mantle Cell Lymphoma Treatment Sales Value, 2019-2030
6.9.2 India Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Mantle Cell Lymphoma Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Astex Pharmaceuticals, Inc.
7.1.1 Astex Pharmaceuticals, Inc. Profile
7.1.2 Astex Pharmaceuticals, Inc. Main Business
7.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.1.4 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Astex Pharmaceuticals, Inc. Recent Developments
7.2 Bayer AG
7.2.1 Bayer AG Profile
7.2.2 Bayer AG Main Business
7.2.3 Bayer AG Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.2.4 Bayer AG Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Bayer AG Recent Developments
7.3 Bristol-Myers Squibb Company
7.3.1 Bristol-Myers Squibb Company Profile
7.3.2 Bristol-Myers Squibb Company Main Business
7.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.3.4 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Celgene Corporation Recent Developments
7.4 Celgene Corporation
7.4.1 Celgene Corporation Profile
7.4.2 Celgene Corporation Main Business
7.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.4.4 Celgene Corporation Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Celgene Corporation Recent Developments
7.5 Cellular Biomedicine Group, Inc.
7.5.1 Cellular Biomedicine Group, Inc. Profile
7.5.2 Cellular Biomedicine Group, Inc. Main Business
7.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.5.4 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Cellular Biomedicine Group, Inc. Recent Developments
7.6 Eisai
7.6.1 Eisai Profile
7.6.2 Eisai Main Business
7.6.3 Eisai Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.6.4 Eisai Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Eisai Recent Developments
7.7 EpiZyme, Inc.
7.7.1 EpiZyme, Inc. Profile
7.7.2 EpiZyme, Inc. Main Business
7.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.7.4 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 EpiZyme, Inc. Recent Developments
7.8 Fate Therapeutics, Inc.
7.8.1 Fate Therapeutics, Inc. Profile
7.8.2 Fate Therapeutics, Inc. Main Business
7.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.8.4 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Fate Therapeutics, Inc. Recent Developments
7.9 Genentech, Inc.
7.9.1 Genentech, Inc. Profile
7.9.2 Genentech, Inc. Main Business
7.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.9.4 Genentech, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Genentech, Inc. Recent Developments
7.10 Gilead Sciences, Inc.
7.10.1 Gilead Sciences, Inc. Profile
7.10.2 Gilead Sciences, Inc. Main Business
7.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.10.4 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Gilead Sciences, Inc. Recent Developments
7.11 GlaxoSmithKline Plc
7.11.1 GlaxoSmithKline Plc Profile
7.11.2 GlaxoSmithKline Plc Main Business
7.11.3 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.11.4 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 GlaxoSmithKline Plc Recent Developments
7.12 Hutchison MediPharma Limited
7.12.1 Hutchison MediPharma Limited Profile
7.12.2 Hutchison MediPharma Limited Main Business
7.12.3 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.12.4 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Hutchison MediPharma Limited Recent Developments
7.13 ImmunoGen, Inc.
7.13.1 ImmunoGen, Inc. Profile
7.13.2 ImmunoGen, Inc. Main Business
7.13.3 ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.13.4 ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 ImmunoGen, Inc. Recent Developments
7.14 Immunomedics, Inc.
7.14.1 Immunomedics, Inc. Profile
7.14.2 Immunomedics, Inc. Main Business
7.14.3 Immunomedics, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
7.14.4 Immunomedics, Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.14.5 Immunomedics, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Mantle Cell Lymphoma Treatment Industrial Chain
8.2 Mantle Cell Lymphoma Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Mantle Cell Lymphoma Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Mantle Cell Lymphoma Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Mantle Cell Lymphoma Treatment Market Trends
Table 2. Mantle Cell Lymphoma Treatment Market Drivers & Opportunity
Table 3. Mantle Cell Lymphoma Treatment Market Challenges
Table 4. Mantle Cell Lymphoma Treatment Market Restraints
Table 5. Global Mantle Cell Lymphoma Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Mantle Cell Lymphoma Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Mantle Cell Lymphoma Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Mantle Cell Lymphoma Treatment
Table 10. Global Mantle Cell Lymphoma Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mantle Cell Lymphoma Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Mantle Cell Lymphoma Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Mantle Cell Lymphoma Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Mantle Cell Lymphoma Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Mantle Cell Lymphoma Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Mantle Cell Lymphoma Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Mantle Cell Lymphoma Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Mantle Cell Lymphoma Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Mantle Cell Lymphoma Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Mantle Cell Lymphoma Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Mantle Cell Lymphoma Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Mantle Cell Lymphoma Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Mantle Cell Lymphoma Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Mantle Cell Lymphoma Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Mantle Cell Lymphoma Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Mantle Cell Lymphoma Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Mantle Cell Lymphoma Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Mantle Cell Lymphoma Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Mantle Cell Lymphoma Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Astex Pharmaceuticals, Inc. Basic Information List
Table 32. Astex Pharmaceuticals, Inc. Description and Business Overview
Table 33. Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Astex Pharmaceuticals, Inc. (2019-2024)
Table 35. Astex Pharmaceuticals, Inc. Recent Developments
Table 36. Bayer AG Basic Information List
Table 37. Bayer AG Description and Business Overview
Table 38. Bayer AG Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Bayer AG (2019-2024)
Table 40. Bayer AG Recent Developments
Table 41. Bristol-Myers Squibb Company Basic Information List
Table 42. Bristol-Myers Squibb Company Description and Business Overview
Table 43. Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Bristol-Myers Squibb Company (2019-2024)
Table 45. Bristol-Myers Squibb Company Recent Developments
Table 46. Celgene Corporation Basic Information List
Table 47. Celgene Corporation Description and Business Overview
Table 48. Celgene Corporation Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Celgene Corporation (2019-2024)
Table 50. Celgene Corporation Recent Developments
Table 51. Cellular Biomedicine Group, Inc. Basic Information List
Table 52. Cellular Biomedicine Group, Inc. Description and Business Overview
Table 53. Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Cellular Biomedicine Group, Inc. (2019-2024)
Table 55. Cellular Biomedicine Group, Inc. Recent Developments
Table 56. Eisai Basic Information List
Table 57. Eisai Description and Business Overview
Table 58. Eisai Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Eisai (2019-2024)
Table 60. Eisai Recent Developments
Table 61. EpiZyme, Inc. Basic Information List
Table 62. EpiZyme, Inc. Description and Business Overview
Table 63. EpiZyme, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of EpiZyme, Inc. (2019-2024)
Table 65. EpiZyme, Inc. Recent Developments
Table 66. Fate Therapeutics, Inc. Basic Information List
Table 67. Fate Therapeutics, Inc. Description and Business Overview
Table 68. Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Fate Therapeutics, Inc. (2019-2024)
Table 70. Fate Therapeutics, Inc. Recent Developments
Table 71. Genentech, Inc. Basic Information List
Table 72. Genentech, Inc. Description and Business Overview
Table 73. Genentech, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Genentech, Inc. (2019-2024)
Table 75. Genentech, Inc. Recent Developments
Table 76. Gilead Sciences, Inc. Basic Information List
Table 77. Gilead Sciences, Inc. Description and Business Overview
Table 78. Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Gilead Sciences, Inc. (2019-2024)
Table 80. Gilead Sciences, Inc. Recent Developments
Table 81. GlaxoSmithKline Plc Basic Information List
Table 82. GlaxoSmithKline Plc Description and Business Overview
Table 83. GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of GlaxoSmithKline Plc (2019-2024)
Table 85. GlaxoSmithKline Plc Recent Developments
Table 86. Hutchison MediPharma Limited Basic Information List
Table 87. Hutchison MediPharma Limited Description and Business Overview
Table 88. Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 89. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Hutchison MediPharma Limited (2019-2024)
Table 90. Hutchison MediPharma Limited Recent Developments
Table 91. ImmunoGen, Inc. Basic Information List
Table 92. ImmunoGen, Inc. Description and Business Overview
Table 93. ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 94. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of ImmunoGen, Inc. (2019-2024)
Table 95. ImmunoGen, Inc. Recent Developments
Table 96. Immunomedics, Inc. Basic Information List
Table 97. Immunomedics, Inc. Description and Business Overview
Table 98. Immunomedics, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 99. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Immunomedics, Inc. (2019-2024)
Table 100. Immunomedics, Inc. Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Mantle Cell Lymphoma Treatment Downstream Customers
Table 104. Mantle Cell Lymphoma Treatment Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Mantle Cell Lymphoma Treatment Product Picture
Figure 2. Global Mantle Cell Lymphoma Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Mantle Cell Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Mantle Cell Lymphoma Treatment Report Years Considered
Figure 5. Global Mantle Cell Lymphoma Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Mantle Cell Lymphoma Treatment Revenue in 2023
Figure 7. Mantle Cell Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Acalabrutinib Picture
Figure 9. JCAR-017 Picture
Figure 10. JNJ-64052781 Picture
Figure 11. Acalisib Picture
Figure 12. IGN-002 Picture
Figure 13. IMGN-529 Picture
Figure 14. AFM-11 Picture
Figure 15. Others Picture
Figure 16. Global Mantle Cell Lymphoma Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Mantle Cell Lymphoma Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Product Picture of Others
Figure 21. Global Mantle Cell Lymphoma Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Mantle Cell Lymphoma Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 23. North America Mantle Cell Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 25. Europe Mantle Cell Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 27. Asia Pacific Mantle Cell Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia Pacific Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. South America Mantle Cell Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 30. South America Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Mantle Cell Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 33. Key Countries/Regions Mantle Cell Lymphoma Treatment Sales Value (%), (2019-2030)
Figure 34. United States Mantle Cell Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 35. United States Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 36. United States Mantle Cell Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 37. Europe Mantle Cell Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 38. Europe Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 39. Europe Mantle Cell Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 40. China Mantle Cell Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 41. China Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 42. China Mantle Cell Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 43. Japan Mantle Cell Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 44. Japan Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 45. Japan Mantle Cell Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 46. South Korea Mantle Cell Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 47. South Korea Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 48. South Korea Mantle Cell Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 49. Southeast Asia Mantle Cell Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 51. Southeast Asia Mantle Cell Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 52. India Mantle Cell Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 53. India Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 54. India Mantle Cell Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 55. Mantle Cell Lymphoma Treatment Industrial Chain
Figure 56. Mantle Cell Lymphoma Treatment Manufacturing Cost Structure
Figure 57. Channels of Distribution (Direct Sales, and Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Table 1. Mantle Cell Lymphoma Treatment Market Trends
Table 2. Mantle Cell Lymphoma Treatment Market Drivers & Opportunity
Table 3. Mantle Cell Lymphoma Treatment Market Challenges
Table 4. Mantle Cell Lymphoma Treatment Market Restraints
Table 5. Global Mantle Cell Lymphoma Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Mantle Cell Lymphoma Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Mantle Cell Lymphoma Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Mantle Cell Lymphoma Treatment
Table 10. Global Mantle Cell Lymphoma Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mantle Cell Lymphoma Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Mantle Cell Lymphoma Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Mantle Cell Lymphoma Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Mantle Cell Lymphoma Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Mantle Cell Lymphoma Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Mantle Cell Lymphoma Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Mantle Cell Lymphoma Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Mantle Cell Lymphoma Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Mantle Cell Lymphoma Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Mantle Cell Lymphoma Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Mantle Cell Lymphoma Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Mantle Cell Lymphoma Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Mantle Cell Lymphoma Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Mantle Cell Lymphoma Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Mantle Cell Lymphoma Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Mantle Cell Lymphoma Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Mantle Cell Lymphoma Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Mantle Cell Lymphoma Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Mantle Cell Lymphoma Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Astex Pharmaceuticals, Inc. Basic Information List
Table 32. Astex Pharmaceuticals, Inc. Description and Business Overview
Table 33. Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Astex Pharmaceuticals, Inc. (2019-2024)
Table 35. Astex Pharmaceuticals, Inc. Recent Developments
Table 36. Bayer AG Basic Information List
Table 37. Bayer AG Description and Business Overview
Table 38. Bayer AG Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Bayer AG (2019-2024)
Table 40. Bayer AG Recent Developments
Table 41. Bristol-Myers Squibb Company Basic Information List
Table 42. Bristol-Myers Squibb Company Description and Business Overview
Table 43. Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Bristol-Myers Squibb Company (2019-2024)
Table 45. Bristol-Myers Squibb Company Recent Developments
Table 46. Celgene Corporation Basic Information List
Table 47. Celgene Corporation Description and Business Overview
Table 48. Celgene Corporation Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Celgene Corporation (2019-2024)
Table 50. Celgene Corporation Recent Developments
Table 51. Cellular Biomedicine Group, Inc. Basic Information List
Table 52. Cellular Biomedicine Group, Inc. Description and Business Overview
Table 53. Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Cellular Biomedicine Group, Inc. (2019-2024)
Table 55. Cellular Biomedicine Group, Inc. Recent Developments
Table 56. Eisai Basic Information List
Table 57. Eisai Description and Business Overview
Table 58. Eisai Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Eisai (2019-2024)
Table 60. Eisai Recent Developments
Table 61. EpiZyme, Inc. Basic Information List
Table 62. EpiZyme, Inc. Description and Business Overview
Table 63. EpiZyme, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of EpiZyme, Inc. (2019-2024)
Table 65. EpiZyme, Inc. Recent Developments
Table 66. Fate Therapeutics, Inc. Basic Information List
Table 67. Fate Therapeutics, Inc. Description and Business Overview
Table 68. Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Fate Therapeutics, Inc. (2019-2024)
Table 70. Fate Therapeutics, Inc. Recent Developments
Table 71. Genentech, Inc. Basic Information List
Table 72. Genentech, Inc. Description and Business Overview
Table 73. Genentech, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Genentech, Inc. (2019-2024)
Table 75. Genentech, Inc. Recent Developments
Table 76. Gilead Sciences, Inc. Basic Information List
Table 77. Gilead Sciences, Inc. Description and Business Overview
Table 78. Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Gilead Sciences, Inc. (2019-2024)
Table 80. Gilead Sciences, Inc. Recent Developments
Table 81. GlaxoSmithKline Plc Basic Information List
Table 82. GlaxoSmithKline Plc Description and Business Overview
Table 83. GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of GlaxoSmithKline Plc (2019-2024)
Table 85. GlaxoSmithKline Plc Recent Developments
Table 86. Hutchison MediPharma Limited Basic Information List
Table 87. Hutchison MediPharma Limited Description and Business Overview
Table 88. Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 89. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Hutchison MediPharma Limited (2019-2024)
Table 90. Hutchison MediPharma Limited Recent Developments
Table 91. ImmunoGen, Inc. Basic Information List
Table 92. ImmunoGen, Inc. Description and Business Overview
Table 93. ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 94. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of ImmunoGen, Inc. (2019-2024)
Table 95. ImmunoGen, Inc. Recent Developments
Table 96. Immunomedics, Inc. Basic Information List
Table 97. Immunomedics, Inc. Description and Business Overview
Table 98. Immunomedics, Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
Table 99. Revenue (US$ Million) in Mantle Cell Lymphoma Treatment Business of Immunomedics, Inc. (2019-2024)
Table 100. Immunomedics, Inc. Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Mantle Cell Lymphoma Treatment Downstream Customers
Table 104. Mantle Cell Lymphoma Treatment Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Mantle Cell Lymphoma Treatment Product Picture
Figure 2. Global Mantle Cell Lymphoma Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Mantle Cell Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Mantle Cell Lymphoma Treatment Report Years Considered
Figure 5. Global Mantle Cell Lymphoma Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Mantle Cell Lymphoma Treatment Revenue in 2023
Figure 7. Mantle Cell Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Acalabrutinib Picture
Figure 9. JCAR-017 Picture
Figure 10. JNJ-64052781 Picture
Figure 11. Acalisib Picture
Figure 12. IGN-002 Picture
Figure 13. IMGN-529 Picture
Figure 14. AFM-11 Picture
Figure 15. Others Picture
Figure 16. Global Mantle Cell Lymphoma Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Mantle Cell Lymphoma Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Product Picture of Others
Figure 21. Global Mantle Cell Lymphoma Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Mantle Cell Lymphoma Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 23. North America Mantle Cell Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 25. Europe Mantle Cell Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 27. Asia Pacific Mantle Cell Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia Pacific Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. South America Mantle Cell Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 30. South America Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Mantle Cell Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Mantle Cell Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 33. Key Countries/Regions Mantle Cell Lymphoma Treatment Sales Value (%), (2019-2030)
Figure 34. United States Mantle Cell Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 35. United States Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 36. United States Mantle Cell Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 37. Europe Mantle Cell Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 38. Europe Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 39. Europe Mantle Cell Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 40. China Mantle Cell Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 41. China Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 42. China Mantle Cell Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 43. Japan Mantle Cell Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 44. Japan Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 45. Japan Mantle Cell Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 46. South Korea Mantle Cell Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 47. South Korea Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 48. South Korea Mantle Cell Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 49. Southeast Asia Mantle Cell Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 51. Southeast Asia Mantle Cell Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 52. India Mantle Cell Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 53. India Mantle Cell Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 54. India Mantle Cell Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 55. Mantle Cell Lymphoma Treatment Industrial Chain
Figure 56. Mantle Cell Lymphoma Treatment Manufacturing Cost Structure
Figure 57. Channels of Distribution (Direct Sales, and Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232